GDF2 and Pulmonary arterial hypertension associated with portal hypertension: This is consistent with reports of reduced circulating BMP9 and BMP10 levels in portopulmonary hypertension patients (Nikolic et al., 2019; Owen et al., 2020; Rochon et al., 2020).